M&A / Deals

Pfizer signs licence agreement with Chai for AI drug discovery

Pharmaceutical Technology

Pfizer and Chai Discovery have signed a licence deal enabling the former to incorporate Chai's AI platform into its drug discovery operations.

Read full story

pharminent June 5, 2026 (Last updated: June 5, 2026)

Pharmaceutical Technology

Pfizer and Chai Discovery have signed a licence deal enabling the former to incorporate Chai’s AI platform into its drug discovery operations.

Read full story